Работайте офлайн с приложением Player FM !
Paxlovid in COVID-19 Vaccinated patients
Manage episode 418005992 series 2931422
Join us as we explore new trial data examing Paxlovid's effectiveness in high-risk, vaccinated patients.
The GameChanger
Significantly high risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccincated patients.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
New England Journal of Medicine Article
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss EPIC SR study findings.
2. Describe benefits of Paxlovid for specific patient groups based on trial data.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-172-H01-P
Initial release date: 05/13/2024
Expiration date: 05/13/2025
Additional CPE details can be found here.
Разделы
1. Paxlovid in COVID-19 Vaccinated patients (00:00:00)
2. COVID Treatment Update and Study Results (00:00:08)
3. Effectiveness of Paxlovid for COVID-19 (00:12:46)
297 эпизодов
Manage episode 418005992 series 2931422
Join us as we explore new trial data examing Paxlovid's effectiveness in high-risk, vaccinated patients.
The GameChanger
Significantly high risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccincated patients.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
New England Journal of Medicine Article
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss EPIC SR study findings.
2. Describe benefits of Paxlovid for specific patient groups based on trial data.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-172-H01-P
Initial release date: 05/13/2024
Expiration date: 05/13/2025
Additional CPE details can be found here.
Разделы
1. Paxlovid in COVID-19 Vaccinated patients (00:00:00)
2. COVID Treatment Update and Study Results (00:00:08)
3. Effectiveness of Paxlovid for COVID-19 (00:12:46)
297 эпизодов
Tất cả các tập
×Добро пожаловать в Player FM!
Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.